MedMen
Mel Elias is a seasoned entrepreneur and board member with extensive experience across various industries, including consumer technology, cannabis, and music production. As co-founder of BRUVI, Elias focuses on innovative coffee brewing solutions and has played a pivotal role in launching the product for direct-to-consumer sales. In addition, Elias is actively involved with MedMen as a board member, contributing to audit and compensation committees, and co-founded Divergent IP, a patent and engineering company. Other key positions include venture partner at Crosscut Ventures, director at Sassoon Investment Corporation, founder of Reverse Bird, and operating advisor at Muertos Coffee Co. Mel Elias also serves in advisory roles for several food and beverage brands and is a non-executive board member at Miroma and Wing Wing. Educational qualifications include a Bachelor of Laws from The London School of Economics and a Coffee Science Certificate.
This person is not in the org chart
This person is not in any offices
MedMen
11 followers
MedMen Enterprises is a leading cannabis company in the U.S. with assets and operations nationwide. MedMen owns and operates licensed cannabis facilities in cultivation, manufacturing and retail, and is the most recognized cannabis brand in the world today. Based in Los Angeles, MedMen employs over 1,100 team members across the U.S. It was founded in 2010 by Adam Bierman and Andrew Modlin, two visionary entrepreneurs who saw not just a tremendous business opportunity in the growing legalization of marijuana, but a chance to redefine our society's relationship with cannabis. The federal prohibition has had a disastrous impact, overpopulating our prisons and enriching violent drug cartels while keeping a relatively benign substance with proven benefits out of the reach of law abiding citizens.